These lines of experimental evidence demonstrate the critical role of HGF/MET and Wnt/β-catenin signaling co-activation in promoting tumor progression and inducing AR and SYN double-negative tumor cells, which is similar to what we have observed in PCa patient samples treated with current ADT. The gene discussed is AR; the disease is posterior cortical atrophy.